Mohammad Nassaji1, Raheb Ghorbani2, Reza Kiaee Afshar3. 1. Associate Professor, Department of Infectious Disease, Social Determinants of Health Research Center, Faculty of Medicine, Semnan University of Medical Sciences , Semnan, Iran . 2. Professor of Biostatistics, Department of Community Medicine, Social Determinants of Health Research Center, Faculty of Medicine, Semnan University of Medical Sciences , Semnan, Iran . 3. General Physician, Department of Internal Medicine, Semnan University of Medical Sciences , Semnan, Iran .
Abstract
BACKGROUND: Beyond their lipid-lowering abilities, statins have anti-inflammatory and immunomodulatory properties. In view of these effects, a growing interest has emerged in the possible role of statins, in preventing or decreasing morbidity and mortality from infection. OBJECTIVES: The aim of this study was to determine whether previous statin use is associated with reduced risk of acute bacterial infections and better outcome of these infections. MATERIALS AND METHODS: In this historical cohort study, consecutive adult patients admitted with acute bacterial infection were enrolled. Control group were selected from adult outpatient and without history of acute bacterial infections. Acute bacterial infections included in this study were; pneumonia, acute pyelonephritis, cellulitis and sepsis with unknown origin. Data about baseline characteristics, co-morbidities and statins use of two groups was obtained. RESULTS: Finally 144 patients met inclusion criteria and were enrolled. Same numbers of controls were selected. Two groups were matched based on most baseline characteristics and co-morbidities. The patients' categories were as follows: pneumonia 42.3%, acute pyelonephritis 23.6%, cellulitis 16% and sepsis 18%. From all participants 29.9% of patients and 45.8% controls were statin users. There was significant association between previous statin use and reduced risk of acute bacterial infections (Mantel Haenszel Weighted Odds Ratio=0.51, 95% CI: 0.30-0.85, p=0.009). Duration of hospitalization was significantly shorter in statin users (p=0.002). Hospital mortality rate was lower (14.6%) in statins users when compared with non-users (18.8%) with significant difference (p=0.028). CONCLUSION: Prior therapy with statins is associated with considerably reduced onset of acute bacterial infections and better outcome in adult patients.
BACKGROUND: Beyond their lipid-lowering abilities, statins have anti-inflammatory and immunomodulatory properties. In view of these effects, a growing interest has emerged in the possible role of statins, in preventing or decreasing morbidity and mortality from infection. OBJECTIVES: The aim of this study was to determine whether previous statin use is associated with reduced risk of acute bacterial infections and better outcome of these infections. MATERIALS AND METHODS: In this historical cohort study, consecutive adult patients admitted with acute bacterial infection were enrolled. Control group were selected from adult outpatient and without history of acute bacterial infections. Acute bacterial infections included in this study were; pneumonia, acute pyelonephritis, cellulitis and sepsis with unknown origin. Data about baseline characteristics, co-morbidities and statins use of two groups was obtained. RESULTS: Finally 144 patients met inclusion criteria and were enrolled. Same numbers of controls were selected. Two groups were matched based on most baseline characteristics and co-morbidities. The patients' categories were as follows: pneumonia 42.3%, acute pyelonephritis 23.6%, cellulitis 16% and sepsis 18%. From all participants 29.9% of patients and 45.8% controls were statin users. There was significant association between previous statin use and reduced risk of acute bacterial infections (Mantel Haenszel Weighted Odds Ratio=0.51, 95% CI: 0.30-0.85, p=0.009). Duration of hospitalization was significantly shorter in statin users (p=0.002). Hospital mortality rate was lower (14.6%) in statins users when compared with non-users (18.8%) with significant difference (p=0.028). CONCLUSION: Prior therapy with statins is associated with considerably reduced onset of acute bacterial infections and better outcome in adult patients.
Authors: Marc W Merx; Elisa A Liehn; Jürgen Graf; Annette van de Sandt; Maren Schaltenbrand; Jürgen Schrader; Peter Hanrath; Christian Weber Journal: Circulation Date: 2005-07-05 Impact factor: 29.690
Authors: Michael W Donnino; Michael N Cocchi; Michael Howell; Peter Clardy; Daniel Talmor; Lauren Cataldo; Maureen Chase; Adel Al-Marshad; Long Ngo; Nathan I Shapiro Journal: Acad Emerg Med Date: 2009-03 Impact factor: 3.451
Authors: Waleed T Kayani; Salman J Bandeali; Vei-Vei Lee; Macarthur Elayda; Anam Khan; Vijay Nambi; Hani Jneid; Mahboob Alam; James M Wilson; Henry D Huang; Yochai Birnbaum; Christie M Ballantyne; Salim S Virani Journal: Int J Cardiol Date: 2012-10-07 Impact factor: 4.164
Authors: Reimar W Thomsen; Heidi H Hundborg; Søren P Johnsen; Lars Pedersen; Henrik T Sørensen; Henrik C Schønheyder; Hans-Henrik Lervang Journal: Crit Care Med Date: 2006-04 Impact factor: 7.598
Authors: Maarten M Bruin; Ruud L M Deijkers; Michaël P A Bus; Erika P M van Elzakker; Roos Bazuin; Rob G Nelissen; Bart G Pijls Journal: J Clin Med Date: 2022-03-26 Impact factor: 4.241
Authors: Justyna Cwajda-Białasik; Paulina Mościcka; Arkadiusz Jawień; Maria Teresa Szewczyk Journal: Int J Environ Res Public Health Date: 2021-12-08 Impact factor: 3.390